Ophir Asset Management Pty LTD Codex Dna, Inc. Transaction History

Ophir Asset Management Pty LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$1.8 - $6.45 $2.37 Million - $8.48 Million	-1,314,510 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.12 - $10.36 $1.64 Million - $4.12 Million	397,467 Added 43.34%	1,314,510 $7.06 Million
Q4 2021 Feb 14, 2022	BUY	$6.31 - $11.96 $1.61 Million - $3.06 Million	255,925 Added 38.71%	917,043 $9.9 Million
Q3 2021 Nov 12, 2021	BUY	$10.15 - $19.88 $6.71 Million - $13.1 Million	661,118 New	661,118 $7.36 Million

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Ophir Asset Management Pty LTD, based on Form 13F filings with the SEC.

Stay updated on Ophir Asset Management Pty LTD with notifications on news.